Medicare's outdated reimbursement system is jeopardizing rural office-based medical practices by underpaying for advanced outpatient procedures, leading to consolidation and increased healthcare costs. Proposed reforms aim to preserve independent care and improve access.
CMS's 2027 Proposed Rule for Medicare Advantage revises Star Ratings by focusing on clinical quality and member experience, delaying equity-focused rewards, and enhancing integrated care for dual-eligible populations.
Orcas Senior Center hosts a free insurance enrollment event on December 6 with support from SHIBA, offering free, unbiased insurance counseling through the Washington State Office of the Insurance Commissioner.
CMS expands Medicare drug price controls to 25 medications, achieving $12 billion savings with new Maximum Fair Prices starting 2026 and 2027 for chronic and cancer treatments.
CMS has proposed key 2027 updates to Medicare Advantage and Part D Star Ratings aiming to streamline quality measures and modernize enrollment options to enhance care and plan accountability.
Kinney Drugs teams with EnlivenHealth to provide free Medicare Part D plan comparisons aiding seniors during Medicare open enrollment. Learn about plan options and enrollment strategies.
Medicare’s 2025 open enrollment period ends December 7. Learn key details on plan options, enrollment processes, and compliance for insurance professionals.
HHS-OIG audit uncovers $39.6 million in potentially improper podiatry E/M payments, urging CMS to enhance Medicare oversight in billing practices.
CMS will conduct a drug acquisition cost survey in early 2026 to collect data from hospitals under the Medicare OPPS, informing 2027 outpatient payment policies.
Key updates on Social Security benefits and Medicare costs for 2026, including COLA increases, enrollment details, tax implications, and program solvency.
